about
Mitochondrial ATP synthase is dispensable in blood-stage Plasmodium berghei rodent malaria but essential in the mosquito phaseLysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.Fatty acid biosynthesis as a drug target in apicomplexan parasites.Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.A serine-arginine-rich (SR) splicing factor modulates alternative splicing of over a thousand genes in Toxoplasma gondii.Chemobiosynthesis of new antimalarial macrolides.Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum.Fatty acid synthesis in protozoan parasites: unusual pathways and novel drug targets.Targeting apicoplasts in malaria parasites.The Plasmodium translocon of exported proteins component EXP2 is critical for establishing a patent malaria infection in mice.Dimeric cyclohexane-1,3-dione oximes inhibit wheat acetyl-CoA carboxylase and show anti-malarial activity.Functional complementation of anthocyanin sequestration in the vacuole by widely divergent glutathione S-transferases.Gamete fusion: key protein identified.A genetic screen in rodent malaria parasites identifies five new apicoplast putative membrane transporters, one of which is essential in human malaria parasites.The effects of anti-bacterials on the malaria parasite Plasmodium falciparum.Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.Host biotin is required for liver stage development in malaria parasites.Identification and analysis of a class 2 alpha-mannosidase from Aspergillus nidulansAlternative splicing is required for stage differentiation in malaria parasites.Synthesis and antimalarial activity of prodigiosenesBed Nets, Insecticides, and Antimalarials: Where to Next?Anti-plasmodial Effects of Zanthoxylum zanthoxyloides
P50
Q30662214-5A063740-599A-4E08-B4B0-892EF68845EBQ33798591-472E0B07-1DE4-4EE8-8BE3-A689BF65146BQ34002198-93220469-4F31-4944-BB84-118892652603Q34974073-515D723E-B803-481B-850B-BCE0E695C0CBQ35102319-B1F4021E-A340-401C-9799-53ABD8952D86Q35786106-1B9882C2-F08C-4AF4-ADCA-132F3474734CQ36558360-F6740132-CFAB-4576-8957-CBC696355EADQ37051193-42074827-EB91-4D09-A755-A783E78F6756Q37160877-465ED552-4674-4E63-84DE-4D7C2E843672Q38066563-9CEF9398-029D-4EA9-B0D0-08BC36F06BD8Q40564865-39FDB486-3430-425A-B45F-AF82097811BEQ43004614-22D83D6D-DA64-4A1C-AC76-83D6CC950259Q46099558-0B967BEA-8605-4683-8C71-F26049595DB6Q47672553-D1A92B2A-7FB2-44B9-A35C-4B05DD1596F9Q47808765-52EBC69E-28C2-43B3-B717-9B3C47E1EE92Q47823743-BC599E17-5E1C-479B-86BE-C891BE3C2E27Q48015411-13E0CDB9-969A-45D1-B678-18BA3C3E6BDBQ50421800-84F3093D-F768-4F8C-ACD0-1D028D2815D2Q62684459-4B22B70E-B0F3-447A-8E2C-7A3B3628A821Q70206968-A27F5D80-A214-47C2-926F-1539F8C63472Q87890014-B571B444-8CCC-418E-85D5-E3D9C0BEB967Q91862667-57901DAD-62D8-489D-830E-351CD2C0D3DEQ92315008-2FD30D5A-1E2F-46CC-8289-DDEFB9B34A99
P50
description
researcher
@en
name
C D Goodman
@en
C D Goodman
@nl
type
label
C D Goodman
@en
C D Goodman
@nl
prefLabel
C D Goodman
@en
C D Goodman
@nl
P106
P31
P496
0000-0002-8923-7594